|
|
|
|
|
|
by refurb
2354 days ago
|
|
|
They can’t get a “composition of matter” patent, since psilocybin is already known. They could get a “method of use” patent that describes treating a co diction with psilocybin. Even without either of those, the FDA will give them 3 years of market exclusivity (no other drugs will be approved). |
|
|